Answers are grounded in this paper and cite their sources.
Covalent adaptable networks (CANs) are polymer networks in which bond formation and cleavage occur dynamically and reversibly. They are intensively investigated for 3D cell culture, as they model a more physiologically representative environment than traditional 2D culture. In most 3D matrices, however, cell retrieval for downstream analysis remains limited, and overcoming this limitation would advance in vitro 3D models for biomedical research. Herein, this limitation is addressed by functionalizing a cytocompatible and thermogelling diblock copolymer comprised of poly(2-methyl-2-oxazoline) and thermoresponsive poly(2-n-propyl-2oxazine) with biogenic, dithiolane-bearing lipoic acid. The resulting copolymer (P-LOx) is designed such that crosslinking forms a disulfide-based CAN, which, combined with the thermogelling behavior of the copolymer backbone, yields doubly reversible hydrogels with three key properties: excellent 3D-printability, long-term shape fidelity, and on-demand degradation under mild conditions. P-LOx-based hydrogels are successfully extruded in 3D bioprinting with NIH-3T3 fibroblasts and interleukin 12 reporter HEK293 cells. After crosslinking, cell-laden hydrogels remain stable in long-term 3D cell culture and support inbound-cytokine / outbound-protein diffusion. The limited cell-adhesive properties of the native P-LOx network are improved in hybrid formulations with bioactive additives. Finally, the established cytocompatible decrosslinking protocol enables non-enzymatic cell retrieval with >95% viability and allows downstream analysis, including flow cytometry.
No takes yet. Share an insight, caveat, or question.
Takmakova et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: